These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25483696)

  • 1. Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines.
    Zang Y; Du D; Ge P; Xu Y; Liu X; Zhang Y; Su W; Kiseleva I; Rudenko L; Xu F; Kong W; Jiang C
    Hum Vaccin Immunother; 2014; 10(12):3642-8. PubMed ID: 25483696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an egg-based potency assay for a trivalent live attenuated influenza vaccine.
    Yeolekar LR; Dhere RM
    Biologicals; 2012 Mar; 40(2):146-50. PubMed ID: 22269606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production.
    Shcherbik S; Sergent SB; Davis WG; Shu B; Barnes J; Kiseleva I; Larionova N; Klimov A; Bousse T
    J Virol Methods; 2014 Jan; 195():18-25. PubMed ID: 24056261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of SYBR green RT-qPCR assay for titrating bivalent live infectious bronchitis vaccines.
    Yang H; Tu K; Zhao Y; Sun L; Zhao J; Zhang G
    J Virol Methods; 2023 Mar; 313():114675. PubMed ID: 36592741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
    Landgraf G; Desheva YA; Rudenko LG
    Virus Res; 2021 Jul; 300():198396. PubMed ID: 33744337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titration of individual strains in trivalent live-attenuated influenza vaccine without neutralization.
    Sirinonthanawech N; Surichan S; Namsai A; Puthavathana P; Auewarakul P; Kongchanagul A
    J Virol Methods; 2016 Nov; 237():154-158. PubMed ID: 27596269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines.
    Lau YF; Santos C; Torres-Vélez FJ; Subbarao K
    J Virol; 2011 Jan; 85(1):76-85. PubMed ID: 20962087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propagation and Titration of Influenza Viruses.
    Karakus U; Crameri M; Lanz C; Yángüez E
    Methods Mol Biol; 2018; 1836():59-88. PubMed ID: 30151569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
    Talaat KR; Karron RA; Callahan KA; Luke CJ; DiLorenzo SC; Chen GL; Lamirande EW; Jin H; Coelingh KL; Murphy BR; Kemble G; Subbarao K
    Vaccine; 2009 Jun; 27(28):3744-53. PubMed ID: 19464558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
    Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP
    PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and application of a one-step duplex real-time reverse transcription polymerase chain reaction assay for the rapid detection of influenza A (H7N9) virus from poultry samples.
    Bao H; Ma Y; Shi J; Zeng X; Zhao Y; Wang X; Chen H
    Arch Virol; 2015 Oct; 160(10):2471-7. PubMed ID: 26179621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC; Li C; Wang J; Girard M; Lorbetskie B; Gravel C; Farnsworth A; Li X; Smith DG; Cyr TD
    Vaccine; 2012 Jul; 30(32):4762-70. PubMed ID: 22643214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of trivalent live influenza vaccines in MDCK cell line.
    Landgraf G; Desheva YA; Rudenko LG
    MethodsX; 2021; 8():101442. PubMed ID: 34430331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR.
    Schalk JA; van den Elzen C; Ovelgönne H; Baas C; Jongen PM
    J Virol Methods; 2004 May; 117(2):179-87. PubMed ID: 15041215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time PCR-based infectivity assay for the titration of turkey hemorrhagic enteritis virus, an adenovirus, in live vaccines.
    Mahsoub HM; Evans NP; Beach NM; Yuan L; Zimmerman K; Pierson FW
    J Virol Methods; 2017 Jan; 239():42-49. PubMed ID: 27829121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.
    Talaat KR; Karron RA; Luke CJ; Thumar B; McMahon BA; Chen GL; Lamirande EW; Jin H; Coelingh KL; Kemble G; Subbarao K
    Vaccine; 2011 Apr; 29(17):3144-8. PubMed ID: 21377509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.
    Isakova-Sivak I; Matyushenko V; Kotomina T; Kiseleva I; Krutikova E; Donina S; Rekstin A; Larionova N; Mezhenskaya D; Sivak K; Muzhikyan A; Katelnikova A; Rudenko L
    Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31288422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation live-attenuated influenza vaccine platforms.
    Ullah S; Ross TM
    Expert Rev Vaccines; 2022 Aug; 21(8):1097-1110. PubMed ID: 35502639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.